Brief: Adial Pharmaceuticals Secures Agreements With Cambrex And Thermo Fisher Scientific
25/06/2025 13:45
June 25 (Reuters) - Adial Pharmaceuticals Inc ADIL.O: ADIAL PHARMACEUTICALS SECURES U.S.-BASED MANUFACTURING THROUGH AGREEMENTS WITH CAMBREX AND THERMO FISHER SCIENTIFIC FOR DRUG SUBSTANCE AND DRUG PRODUCT SUPPLY ADIAL PHARMACEUTICALS INC - EXECUTES AGREEMENTS FOR AD04 PRODUCTION Source text: ID:nGNX2gQlTX Further company coverage: ADIL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adial Pharmaceuticals
See all newsBrief: Adial Pharmaceuticals Announces Name Change To Azora Therapeutics
Brief: Adial Pharmaceuticals Announces Planned Appointment Of Celia Economides As Chief Financial Officer
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Adial Pharmaceuticals - Proposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling Stockholders - SEC Filing
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)